Investor
The DynamiCare Health platform is already deployed in seven addiction treatment programs within the US.
The new money will be put towards research and development, as well as growing brand awareness in the Americas, Europe and Asia.
The startup's latest funding round will be used to expand its clinician outreach and internal teams.
Biolinq's new funding was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.
The round was led by BIP Capital and Atlanta Technology Angels.
The Providence-St. Joseph Health spinoff's platform allows clinicians to prescribe apps and other digital tools to patients through their normal EHR workflow.
Roughly half of the market will be within the US alone, although China and India are also poised for growth.
The company will be listing its shares on the Nasdaq exchange, and has hired Barclays, Goldman Sachs and JP Morgan as its underwriters.
The company's software enables a more holistic approach to combatting the social determinants of health.